Skip to Main Content
Table 4.

Multivariable analysis of odds for PSMA-PET M1 disease (n = 200)

Variablen (%)OR95% CIP
Age ≥65 years 151 (76) 0.6 0.3–1.3 0.23 
Gleason score of ≥8 151 (76) 1.1 0.5–2.3 0.80 
PSA ≥5.5 ng/mL 97 (49) 2.0 1.1–3.6 0.03a 
PSADT of ≤6 months (n = 132b85 (43) 1.6 0.8–3.3 0.22 
Locoregional disease pN1 45 (23) 2.7 1.3–6.0 0.01a 
RPE and SRT 40 (20) 4.6 2.0–11.0 <0.01a 
PRT 64 (32) 3.1 1.5–6.1 0.02a 
Variablen (%)OR95% CIP
Age ≥65 years 151 (76) 0.6 0.3–1.3 0.23 
Gleason score of ≥8 151 (76) 1.1 0.5–2.3 0.80 
PSA ≥5.5 ng/mL 97 (49) 2.0 1.1–3.6 0.03a 
PSADT of ≤6 months (n = 132b85 (43) 1.6 0.8–3.3 0.22 
Locoregional disease pN1 45 (23) 2.7 1.3–6.0 0.01a 
RPE and SRT 40 (20) 4.6 2.0–11.0 <0.01a 
PRT 64 (32) 3.1 1.5–6.1 0.02a 

Abbreviations: PRT, primary radiotherapy; RPE, radical prostatectomy; SRT, salvage radiotherapy.

aP < 0.05.

bOn the basis of univariate analysis.

Close Modal

or Create an Account

Close Modal
Close Modal